Answers are grounded in this paper and cite their sources.
Relapsed/refractory mantle cell lymphoma (MCL) is an aggressive, non-Hodgkin's B-cell lymphoma with a poor long-term survival rate and suboptimal responses to multiple conventional treatments. This case report will detail a case of a patient with relapsed/refractory MCL that was treated with percutaneous cryoablation for a localized recurrence and no evidence of further relapse two years post-ablation.
No takes yet. Share an insight, caveat, or question.
Aoun et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: